ADMA Biologics, Inc. (ADMA)

ADMA Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	4,113	1,021	857	276	184	237
Market Cap Growth	478.68%	19.17%	210.43%	49.75%	-22.30%	114.19%
Enterprise Value	4,138	1,100	975	343	225	274
Last Close Price	17.40	4.52	3.88	1.41	1.95	4.00
Forward PE	25.65	36.16	-	-	-	-
PS Ratio	10.48	3.96	5.56	3.41	4.37	8.08
PB Ratio	17.74	7.55	5.64	1.96	2.09	9.06
P/TBV Ratio	20.45	7.79	5.81	2.03	2.24	12.17
P/FCF Ratio	51.81	253.51	-	-	-	-
P/OCF Ratio	47.80	116.07	-	-	-	-
EV/Sales Ratio	10.81	4.26	6.33	4.24	5.33	9.32
EV/EBITDA Ratio	32.87	33.59	-	-	-	-
EV/EBIT Ratio	35.16	45.03	-	-	-	-
EV/FCF Ratio	52.12	273.07	-	-	-	-
Debt / Equity Ratio	0.48	1.05	1.02	0.73	1.11	3.23
Debt / EBITDA Ratio	0.87	4.02	-	-	-	-
Debt / FCF Ratio	1.40	35.10	-	-	-	-
Asset Turnover	1.04	0.76	0.49	0.33	0.25	0.27
Inventory Turnover	1.15	0.99	0.83	0.77	0.80	1.10
Quick Ratio	3.05	1.58	2.60	2.62	3.47	2.15
Current Ratio	7.09	5.16	6.89	6.87	7.71	6.12
Return on Equity (ROE)	35.55%	-19.67%	-44.96%	-62.46%	-132.38%	-210.08%
Return on Assets (ROA)	19.89%	4.51%	-7.88%	-14.87%	-21.44%	-23.98%
Return on Capital (ROIC)	22.71%	5.24%	-8.94%	-16.74%	-24.18%	-30.08%
Earnings Yield	1.66%	-2.76%	-7.69%	-25.95%	-41.09%	-20.35%
FCF Yield	1.93%	0.39%	-8.57%	-45.59%	-62.23%	-33.72%
Buyback Yield / Dilution	-8.99%	-13.19%	-41.77%	-62.03%	-58.51%	-20.27%
Total Shareholder Return	-8.99%	-13.19%	-41.77%	-62.03%	-58.51%	-20.27%

Source: S&P Capital IQ. Standard template. Financial Sources.